What is the current Price Target for the Viracta Therapeutics Inc stock?

The average Viracta Therapeutics Inc target price is $1.63. This is 915.63% higher than the current stock price. The highest price target is 1,775.00%, the lowest is 56.25%. 2 Analysts have issued a price target Viracta Therapeutics Inc 2025 .

How high will the Viracta Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Viracta Therapeutics Inc stock will rise. The performance of stocks, including the Viracta Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Viracta Therapeutics Inc stock today?

The performance of Viracta Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Viracta Therapeutics Inc stock fall?

The decline in Viracta Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Viracta Therapeutics Inc Forecast, price target & analysts

$0.16

0.00% yesterday

Nasdaq, Dec 30, 10:19 pm CET

ISIN

US92765F1084

Symbol

VIRX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Viracta Therapeutics Inc Target price 2024 - Analyst rating & recommendation

Viracta Therapeutics Inc Classifications & Recommendation:

Hold

100%

Viracta Therapeutics Inc Price Target

Target Price	$1.63
Price	$0.16
Potential	915.63% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Viracta Therapeutics Inc 2025 . The average Viracta Therapeutics Inc target price is $1.63. This is 915.63% register free of charge higher than the current stock price. The highest price target is $3.00 1,775.00% register free of charge , the lowest is $0.25 56.25% register free of charge .
	A rating was issued by 2 analysts: 0 Analysts recommend Viracta Therapeutics Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Viracta Therapeutics Inc stock has an average upside potential 2025 of 915.63% register free of charge . Most analysts recommend the Viracta Therapeutics Inc stock at Hold.

Discover more stocks with a high price target

Valneva 268.86%

CureVac N.V. 117.96%

Moderna 81.31%

Bavarian Nordic 59.49%

Teamviewer 56.15%

RWE 47.84%

Nel ASA 47.09%

Alibaba Group Holding Ltd 43.74%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today